Abstract
Mirtazapine is an antidepressant blocking presynaptic alpha2-adrenergic receptors and an antagonist of 5-hydroxytryptamine 2A/2C, 5-hydroxytryptamine 3, and histaminergic (H) postsynaptic receptor. Acute dystonia restless legs syndrome (RLS) and manic syndromes are adverse effects of mirtazapine, whereas only few cases of acute akathisia, after the first doses of mirtazapine, are referred. Instead, mirtazapine is used to treat akathisia probably because of its antagonistic property at H1 postsynaptic receptors and dopaminergic action in the frontal cortex. A 72-year-old woman with depression, on mirtazapine treatment for almost 20 years, was admitted to an outpatient neurology clinic, with 1-week history of 3-kg weight loss and progressive intense "inner restlessness," constant movements of the legs and feet, remarkable distress, insomnia, and pacing up and down. Neurological examination had normal results, no deterioration of the depression was present, a magnetic resonance scan of the brain was unremarkable, and biochemical tests were within reference ranges. The disorder eventually resolved after the permanent withdrawal of the offending medication. After excluding other possible disorders, the diagnosis of severe akathisia,...Continue Reading
References
May 1, 1989·The British Journal of Psychiatry : the Journal of Mental Science·T R Barnes
Mar 1, 1995·International Clinical Psychopharmacology·C Katona
Dec 1, 1995·International Clinical Psychopharmacology·S A Montgomery
Aug 7, 1998·Journal of Psychopharmacology·R M Lane
Nov 10, 2000·Pharmacopsychiatry·M Marsálek
Aug 8, 2001·The Journal of Clinical Psychiatry·J ChelbenY Baruch
May 22, 2002·The Journal of Clinical Psychiatry·Rui LuMark Gourley
Nov 1, 2002·International Clinical Psychopharmacology·N H BhanjiG Chouinard
Jan 18, 2003·The Journal of Clinical Psychiatry·Mehmed Yucel AğargünOmer Akil Ozer
Jan 18, 2003·The Journal of Clinical Psychiatry·James H MacCabeRobin M Murray
Nov 1, 2003·Sleep Medicine·Richard P AllenUNKNOWN International Restless Legs Syndrome Study Group
Feb 12, 2004·Journal of Psychopharmacology·Lars Hansen
Feb 26, 2005·Movement Disorders : Official Journal of the Movement Disorder Society·Spiros KonitsiotisVenos Mavreas
Feb 25, 2006·Biological Psychiatry·Michael PoyurovskyAbraham Weizman
Mar 30, 2006·The Annals of Pharmacotherapy·Sanjeev RanjanArun Gupta
Jul 16, 2008·Journal of Clinical Psychopharmacology·Murat Gulsun, Ali Doruk
Citations
Nov 12, 2015·Therapeutic Advances in Psychopharmacology·Samir Kumar PraharajPodila Satya Venkata Narasimha Sharma
Jul 15, 2011·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·Crystal C WatkinsGlenn J Treisman
Jun 18, 2020·BMC Psychiatry·Alexis RevetThi Thu Ha Nguyen
Nov 10, 2020·Tzu Chi Medical Journal·Jamir Pitton Rissardo, Ana Leticia Fornari Caprara